Friday, May 1, 2026

Unlocking AI in Healthcare: How Synthetic Data is Revolutionizing Personalized Medical Services

South Korea's regulatory exemptions boost medical AI development with synthetic data, enhancing personalized healthcare and hydrogen energy innovations.

Korean Firms Accelerate U.S. Rare Earth Push to Cut Reliance on China

South Korean firms are establishing rare earth production hubs in the U.S. to reduce reliance on China, supported by government funding.

Alpha Tau Medical’s Alpha DaRT: A New Hope for Pancreatic Cancer Patients – What You Need to Know

Alpha Tau Medical will present clinical results of its DaRT technology for pancreatic cancer at DDW 2026, marking a significant milestone.

Tag: global

Samsung Bioepis Expands SB15 Eylea Rival: Licensing Pact Targets Global Markets as Original Drug Hits $10.5B Sales

Samsung Bioepis has secured a licensing deal for its ophthalmic treatment SB15, expanding access in international markets outside the US and Canada.

From CES 2026 to 200 Countries: How Korean AI Startups Are Testing Global Demand

Wadiz supports global expansion for innovative Korean companies at CES 2026, offering consulting and resources for market entry.

The Robotic Thyroid Surgery With No Neck Scar: 500 Procedures Signal a New Global Standard

Dr. Lee Jin Wook Lee announces 500 successful cases of SPRA, a minimally invasive thyroid cancer surgery, enhancing safety and aesthetics.

Humanoid Robots in Logistics: Will CJ Logistics and Lotte’s AI Innovations Transform the Industry?

South Korean logistics firms are testing humanoid robots to enhance efficiency, aiming to assist in complex tasks traditionally done by humans.

Why Ebola Now? SK Bioscience Joins a $30 Million Global Push to Rethink Ebola Vaccine Production

SK Bioscience secures funding to enhance Ebola vaccine production, improving yield and stability for better accessibility amid outbreaks.

Revolutionizing Regenerative Medicine: Rokit Healthcare’s AI Partnership with the UAE’s Leading Healthcare Firm

Rokit Healthcare partners with UAE's largest healthcare firm to expand its AI-driven regenerative medicine in the Middle East and globally.

CKDB-501A vs. Botox: Can CKD BiO’s New Botulinum Toxin Compete in China’s Booming Market?

Jongkundang Bio has successfully completed Phase 3 trials in China's botulinum toxin market, signaling global expansion.

Unlocking the Future of Health Supplements: HLB Global and Nodcure’s Game-Changing Partnership

HLB Global partners with Nodcure for joint development of next-gen health supplements, aiming to innovate and expand market reach.

From Hair Loss to Inflammation: JW Pharmaceutical Showcases Pipeline to Global Pharma at JPMorgan

JW Pharmaceutical participated in the JP Morgan Healthcare Conference, discussing potential drug partnerships and licensing deals.

Unlocking Global Biotech: CGB-CIC Innovation Center Launching in 2026

CHA Bio Group partners with CIC to create a global bio-ecosystem, enhancing support for biotech firms in cell and gene therapy.

K-Bio Revolution: How Korean Biopharmaceuticals Are Conquering the Global Market in 2026

South Korea's pharmaceutical industry thrives with innovative drugs like botulinum toxins and cancer treatments, targeting global markets.

How Celltrion Plans to Expand Its Biosimilar Portfolio to 41 Products by 2038

Celltrion unveils its growth strategy at the JP Morgan Healthcare Conference, aiming to expand biosimilars and develop new drug pipelines.

Samsung Biologics Unveils Three-Pillar Growth Strategy: How Capacity, Portfolio, and Global Expansion Shape 2026

Samsung Biologics outlines a growth strategy focused on production, portfolio, and global expansion to enhance its CDMO position.

Measles Outbreak: Why the U.S. Sees Highest Cases in 33 Years – What You Need to Know

Measles cases surge in the U.S. with a sevenfold increase in 2023, prompting health officials to urge vaccinations for travelers.

Top News

- Our Sponsors Ad -

Follow us